Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 985-992

  Chen, Fenghua ^a   Xu, Chang ^a   Du, Liqing ^a   Wang, Yan ^a   Cao, Jia ^a   Fu, Yue ^a   Guo, Yanting ^a   Liu, Qiang ^a   Fan, Feiyue ^a  

^a INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Apoptosis; Caspase; Radiation; Radiosensitization; Smac

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; MITOCHONDRIAL PROTEIN; PROTEIN; RNA; TAT SMACN7 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; RNA EXTRACTION; TREATMENT DURATION; WESTERN BLOTTING; XENOGRAFT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITORS; CELL LINE, TUMOR; GENE PRODUCTS, TAT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, NUDE; MITOCHONDRIAL PROTEINS; NEOPLASM TRANSPLANTATION; PEPTIDES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84873642365     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1785     Document Type: Article

References (34)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
2. Hotchkiss RS, Strasser A, McDunn JE and Swanson PE: Cell death. N Engl J Med 361: 1570-1583, 2009.
3. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 281: 1305-1308, 1998. (Pubitemid 28406815)
4. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999. (Pubitemid 32250377)
5. Vaux DL and Korsmeyer SJ: Cell death in development. Cell 96: 245-254, 1999. (Pubitemid 29059354)
6. Van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ and Vandenabeele P: The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9: 1031-1042, 2002.
7. Zou H, Li Y, Liu X and Wang X: An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 274: 11549-11556, 1999.
8. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P and Flavell RA: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337, 1998. (Pubitemid 28376077)
9. Gyrd-Hansen M and Meier P: IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nat Rev Cancer 10: 561-574, 2010.
10. Altieri DC: Survivin and IAP proteins in cell-death mechanisms. Biochem J 430: 199-205, 2010.
11. Suzuki Y, Nakabayashi Y, Nakata K, Reed JC and Takahashi R: X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J Biol Chem 276: 27058-27063, 2001.
12. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R and Shi Y: Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11: 519-527, 2003. (Pubitemid 36293842)
13. Deveraux QL and Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
14. Wagenknecht B, Glaser T, Naumann U, Kügler S, Isenmann S, Bähr M, Korneluk R, Liston P and Weller M: Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6: 370-376, 1999. (Pubitemid 29186881)
15. Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
16. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
17. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116, 2001. (Pubitemid 32225846)
18. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y: Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862, 2000. (Pubitemid 30664254)
19. Green DR: Apoptotic pathways: paper wraps stone blunts scissors. Cell 102: 1-4, 2000.
20. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X and Shi Y: Structural basis of IAP recognition by Smac/DIABLO. Nature 408: 1008-1012, 2000. (Pubitemid 32101651)
21. Giagkousiklidis S, Vogler M, Westhoff MA, Kasperczyk H, Debatin KM and Fulda S: Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase. Cancer Res 65: 10502-10513, 2005. (Pubitemid 41743746)
22. Giagkousiklidis S, Vellanki SH, Debatin KM and Fulda S: Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene 26: 7006-7016, 2007. (Pubitemid 350014607)
23. Vellanki SH, Grabrucker A, Liebau S, Proepper C, Eramo A, Braun V, Boeckers T, Debatin KM and Fulda S: Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma. Neoplasia 11: 743-752, 2009.
24. Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S, Miller RS, Yi H, Shangary S, Sun Y, Meagher JL, Stuckey JA and Wang S: SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Res 68: 9384-9393, 2008.
25. Sun H, Nikolovska-Coleska Z, Lu J, Meagher JL, Yang CY, Qiu S, et al: Design, synthesis and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. J Am Chem Soc 129: 15279-15294, 2007. (Pubitemid 350247811)
26. Yang J, McEachern D, Li W, Davis MA, Li H, Morgan MA, Bai L, Sebolt JT, Sun H, Lawrence TS, Wang S and Sun Y: Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. Mol Cancer Ther 10: 658-669, 2011.
27. Fulda S, Wick W, Weller M and Debatin KM: Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808-815, 2002.
28. Qin L, Tong T, Song Y, Xue L, Fan F and Zhan Q: Aurora-A interacts with Cyclin B1 and enhances its stability. Cancer Lett 275: 77-85, 2009.
29. Bockbrader KM, Tan M and Sun Y: A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL-and etoposide-induced apoptosis in breast cancer cells. Oncogene 24: 7381-7388, 2005. (Pubitemid 41622242)
30. Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
31. Mow BM, Blajeski AL, Chandra J and Kaufmann SH: Apoptosis and the response to anticancer therapy. Curr Opin Oncol 13: 453-462, 2001. (Pubitemid 33027897)
32. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000. (Pubitemid 30137934)
33. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
34. Tait SW and Green DR: Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632, 2010.